Loading stock data...
Last Updated: 16 Feb 2026, 08:22:39 AM (IST)

Ganga Pharmaceuticals Limited

BSE: GANGAPHARM

BSE
12.00 0.00 (0.00%)

Prev Close

12

Open Price

12

Volume

8,000

Today Low / High

12 / 12

52 WK Low / High

9.25 / 17

Range

11 - 13

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 12, reflecting a change of 0 (0%). The expected target range on the BSE is 11 - 13. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

Ganga Pharmaceuticals Limited Graph

Ganga Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Ganga Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 12.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 12.00 12.12 10.91 - 13.33
12.24 9.79 - 14.69
12.36 8.65 - 16.07
Bearish Scenario 12.00 11.88 10.69 - 13.07
11.76 9.41 - 14.11
11.64 8.15 - 15.13

Overview of Ganga Pharmaceuticals Limited

ISIN

INE615T01017

Industry

Medical - Pharmaceuticals

Vol.Avg

1,142

Market Cap

70,938,000

Last Dividend

0

Official Website

Visit Website

IPO Date

2016-02-22

DCF Diff

22.26

DCF

-10

Financial Ratios Every Investor Needs

Stock Rating Details for GANGAPHARM

Metric Value Recommendation
Overall Rating B- Sell
DCF Score 1 Strong Sell
ROE Score 3 Neutral
ROA Score 3 Neutral
Debt-to-Equity (DE) Score 2 Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 4 Buy

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 2.64 Cr 1.21 Cr 1.42 Cr 0.5394 0.00 Cr 0.96 Cr -0.16 Cr 0.08 Cr 0.10 0.32 Cr 0.0300
2024-03-31 2.74 Cr 1.25 Cr 1.49 Cr 0.5446 0.00 Cr 0.85 Cr 0.01 Cr 0.05 Cr 0.11 0.30 Cr 0.0170
2023-03-31 2.59 Cr 1.24 Cr 1.35 Cr 0.5208 0.00 Cr 0.83 Cr -0.05 Cr 0.04 Cr 0.10 0.30 Cr 0.0152
2022-03-31 2.49 Cr 1.28 Cr 1.21 Cr 0.4873 0.00 Cr 0.09 Cr -0.01 Cr 0.04 Cr 0.09 0.30 Cr 0.0152
2021-03-31 2.37 Cr 1.24 Cr 1.14 Cr 0.4792 0.00 Cr 0.12 Cr -0.02 Cr 0.02 Cr 0.05 0.27 Cr 0.0086

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.30 Cr 8.97 Cr 1.84 Cr 7.1314 Cr 1.42 Cr 1.12 Cr 1.18 Cr 0.66 Cr 0.00 Cr 0.00 Cr 0.00 Cr 1.6032 Cr
2024-03-31 0.03 Cr 8.65 Cr 1.60 Cr 7.0526 Cr 1.36 Cr 1.33 Cr 1.24 Cr 0.61 Cr 0.00 Cr 0.00 Cr 0.00 Cr 1.1955 Cr
2023-03-31 0.03 Cr 7.98 Cr 2.53 Cr 5.4501 Cr 1.83 Cr 1.80 Cr 1.18 Cr 0.64 Cr 0.00 Cr 0.00 Cr 0.00 Cr 1.8948 Cr
2022-03-31 0.02 Cr 8.00 Cr 2.58 Cr 5.4108 Cr 1.93 Cr 1.91 Cr 1.15 Cr 0.68 Cr 0.00 Cr 0.00 Cr 0.00 Cr 1.6856 Cr
2021-03-31 0.01 Cr 7.66 Cr 2.29 Cr 5.3729 Cr 1.73 Cr 1.71 Cr 1.13 Cr 0.72 Cr 0.00 Cr 0.00 Cr 0.00 Cr 1.6062 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -0.5772 Cr 1.1813 Cr -0.3315 Cr -0.6759 Cr 0.2726 Cr 0.3024 Cr -0.0987 Cr 0.0947 Cr -0.1629 Cr 0.0000 Cr 0.0591 Cr
2024-03-31 -1.2640 Cr 0.1296 Cr 1.1352 Cr -1.2864 Cr 0.0008 Cr 0.0298 Cr -0.0224 Cr 0.0466 Cr -0.2398 Cr 0.0000 Cr -0.0586 Cr
2023-03-31 -0.0399 Cr 0.4923 Cr -0.4439 Cr -0.0547 Cr 0.0086 Cr 0.0290 Cr -0.0148 Cr 0.0531 Cr -0.2571 Cr 0.0000 Cr -0.0328 Cr
2022-03-31 -0.2107 Cr 0.1893 Cr 0.0273 Cr -0.2254 Cr 0.0059 Cr 0.0204 Cr -0.0147 Cr 0.0512 Cr 0.2177 Cr 0.0000 Cr -0.0171 Cr
2021-03-31 -0.1755 Cr 0.2762 Cr -0.0979 Cr -0.1923 Cr 0.0028 Cr 0.0145 Cr -0.0168 Cr 0.0374 Cr 0.0812 Cr 0.0000 Cr -0.0933 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 1.33 Cr 0.60 Cr 0.73 Cr 0.5506 -0.05 Cr 0.05 Cr 0.05 0.43 Cr 0.0414
2024-09-30 1.31 Cr 0.62 Cr 0.69 Cr 0.5281 -0.11 Cr 0.02 Cr 0.05 -0.11 Cr 0.0184
2024-03-31 1.42 Cr 0.63 Cr 0.79 Cr 0.5570 0.74 Cr 0.03 Cr 0.07 0.01 Cr 0.0215
2023-09-30 1.32 Cr 0.62 Cr 0.70 Cr 0.5277 0.05 Cr 0.02 Cr 0.04 0.05 Cr 0.0123
2023-03-31 1.23 Cr 0.63 Cr 0.61 Cr 0.4907 0.47 Cr 0.01 Cr 0.02 -0.07 Cr 0.0062

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 0.30 Cr 0.00 Cr 0.30 Cr 3.45 Cr 1.18 Cr 6.87 Cr 0.66 Cr 8.97 Cr 1.84 Cr
2024-09-30 0.48 Cr 0.00 Cr 0.48 Cr 1.00 Cr 1.17 Cr 6.97 Cr 0.60 Cr 9.01 Cr 1.93 Cr
2024-03-31 0.03 Cr 0.00 Cr 0.03 Cr 2.43 Cr 1.24 Cr 5.75 Cr 0.61 Cr 8.65 Cr 1.60 Cr
2023-09-30 0.02 Cr 0.00 Cr 0.02 Cr 2.79 Cr 1.22 Cr 5.64 Cr 0.63 Cr 7.80 Cr 2.33 Cr
2023-03-31 0.03 Cr 0.00 Cr 0.03 Cr 0.00 Cr 1.18 Cr 5.15 Cr 0.64 Cr 7.98 Cr 2.53 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-03-31 0.08 Cr 0.13 Cr 0.05 Cr -0.36 Cr 0.30 Cr 0.30 Cr 0.00 Cr -0.09 Cr 0.04 Cr
2024-09-30 0.02 Cr -0.71 Cr 1.13 Cr 0.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr -0.01 Cr -0.71 Cr
2024-03-31 0.03 Cr -0.51 Cr -0.61 Cr 1.13 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -0.52 Cr
2023-09-30 0.02 Cr -0.75 Cr 0.74 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -0.02 Cr -0.77 Cr
2023-03-31 0.01 Cr 0.02 Cr 0.30 Cr -0.31 Cr 0.00 Cr 0.00 Cr 0.00 Cr -0.01 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹830.35 ₹99,644,807,413.00 ₹76,499.00

Key Executives

Chief Financial Officer
Anagh Bharat Sharma

Gender: male

Year Born:

Chief Executive Officer, MD & Executive Director
Bharat Brijmohan Sharma

Gender: male

Year Born: 1964

Compliance Officer & Company Secretary
Priti Kothari Bhaiya

Gender: female

Year Born:

Quality Control Manager & Whole Time Director
Srijana Bharat Sharma

Gender: female

Year Born: 1965

FAQs about Ganga Pharmaceuticals Limited

Who is the CEO of the company?

The CEO is Bharat Brijmohan Sharma.

What is the current market price of the stock?

The current price is ₹12.00.

What is the 52-week price range?

The range is ₹9.25-17.

What is the market capitalization of the company?

The market capitalization is ₹7.09 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 123.12.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Ganga Pharmaceuticals Limited (ISIN: INE615T01017) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹7.09 crores and an average daily volume of 1,142 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.